Effectiveness and safety of PARP inhibitors in ovarian cancer: An umbrella review of systematic reviews and meta-analyses.
- DOI
- 10.1016/j.critrevonc.2025.104893
- Published
- 2025 Nov
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2025.104893,
title = {Effectiveness and safety of PARP inhibitors in ovarian cancer: An umbrella review of systematic reviews and meta-analyses.},
author = {Tzang CC and Huang ES and Wu HW and Lin WC and Lee YT and Luo CA and Chen YH and Chang ZY and Chen ZT and Kuo VF and Tzang BS and Hsu TC},
year = {2025},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2025.104893},
url = {https://doi.org/10.1016/j.critrevonc.2025.104893}
}RIS
TY - JOUR TI - Effectiveness and safety of PARP inhibitors in ovarian cancer: An umbrella review of systematic reviews and meta-analyses. AU - Tzang CC AU - Huang ES AU - Wu HW AU - Lin WC AU - Lee YT AU - Luo CA AU - Chen YH AU - Chang ZY AU - Chen ZT AU - Kuo VF AU - Tzang BS AU - Hsu TC PY - 2025 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2025.104893 UR - https://doi.org/10.1016/j.critrevonc.2025.104893 ER -
APA
CC, T., ES, H., HW, W., WC, L., YT, L., CA, L., YH, C., ZY, C., ZT, C., VF, K., BS, T., & TC, H. (2025). Effectiveness and safety of PARP inhibitors in ovarian cancer: An umbrella review of systematic reviews and meta-analyses.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2025.104893
Source records
- pubmed · retrieved 2026-09-25T17:27:27.302Z